Hidekatsu Nakai
- Reproductive Medicine top 1%
- Oncology top 10%
- Obstetrics and Gynecology top 1%
- Molecular Biology
- Immunology
- Co-authors
- Noriomi MatsumuraMasaki MandaiHisamitsu TakayaYoh WatanabeHiroshi HoshiaiShiro TakamatsuKosuke MurakamiYasushi Kotani
- Topics
- Ovarian cancer diagnosis and treatment (42 papers)Endometrial and Cervical Cancer Treatments (27 papers)Endometriosis Research and Treatment (15 papers)
- Journals
- Journal of Clinical OncologyScientific ReportsAmerican Journal of Obstetrics and Gynecology
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hidekatsu Nakai
73 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 81
- Reproductive Medicine 667
- Oncology 445
- Obstetrics and Gynecology 418
- Molecular Biology 323
- Immunology 207
Countries citing papers authored by Hidekatsu Nakai
This map shows the geographic impact of Hidekatsu Nakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidekatsu Nakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidekatsu Nakai more than expected).
Fields of papers citing papers by Hidekatsu Nakai
This network shows the impact of papers produced by Hidekatsu Nakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidekatsu Nakai. The network helps show where Hidekatsu Nakai may publish in the future.
Co-authorship network of co-authors of Hidekatsu Nakai
This figure shows the co-authorship network connecting the top 25 collaborators of Hidekatsu Nakai. A scholar is included among the top collaborators of Hidekatsu Nakai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidekatsu Nakai. Hidekatsu Nakai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 9 | |
| 4 | 7 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 12 | |
| 9 | 0 | |
| 10 | 2 | |
| 11 | 9 | |
| 12 | 3 | |
| 13 | 3 | |
| 14 | 7 | |
| 15 | 12 | |
| 16 | 4 | |
| 17 | 9 | |
| 18 | 9 | |
| 19 | 11 | |
| 20 | 24 |
About Hidekatsu Nakai
Hidekatsu Nakai is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (42 papers), Endometrial and Cervical Cancer Treatments (27 papers) and Endometriosis Research and Treatment (15 papers). The work is most often cited by research in Reproductive Medicine (667 citations), Obstetrics and Gynecology (418 citations) and Oncology (445 citations). Hidekatsu Nakai has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Noriomi Matsumura, Masaki Mandai, Hisamitsu Takaya, Yoh Watanabe, Hiroshi Hoshiai, Shiro Takamatsu, Kosuke Murakami, Yasushi Kotani, Ayako Suzuki and Haruhiko Ueda. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and American Journal of Obstetrics and Gynecology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.